These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 23484340)

  • 1. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of trypanosomiasis and leishmaniasis.
    Barrett MP; Croft SL
    Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities for zoonoses and marginalized infections.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (971):ix-xi, 1-119, 2 p following 119. PubMed ID: 23420951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
    Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
    Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
    Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
    Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
    Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
    Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Travelers' tropical skin diseases: Challenges and interventions.
    Cunha PR; Flora TB; Kroumpouzos G
    Dermatol Ther; 2019 Jul; 32(4):e12665. PubMed ID: 30216601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy and prophylaxis of systemic protozoan infections.
    Van Voorhis WC
    Drugs; 1990 Aug; 40(2):176-202. PubMed ID: 2121456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 17. Parasite prolyl oligopeptidases and the challenge of designing chemotherapeuticals for Chagas disease, leishmaniasis and African trypanosomiasis.
    Bastos IM; Motta FN; Grellier P; Santana JM
    Curr Med Chem; 2013; 20(25):3103-15. PubMed ID: 23514419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological approaches to antitrypanosomal chemotherapy.
    Croft SL
    Mem Inst Oswaldo Cruz; 1999; 94(2):215-20. PubMed ID: 10224531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.